Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06228742
Other study ID # 24-02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 20, 2024
Est. completion date May 2025

Study information

Verified date April 2024
Source United States Army Research Institute of Environmental Medicine
Contact Emily E Howard, PhD
Phone 508-206-2309
Email emily.e.howard14.civ@health.mil
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will characterize intramuscular molecular mechanisms underlying anabolic resistance to protein ingestion during muscle disuse. Adults (n=12) will be studied using a unilateral leg immobilization model in which one leg will be randomly assigned to immobilization and the contralateral, active leg used as a within-subjects control. Immobilization will be implemented for five days using a rigid knee brace, during which time participants will ambulate using crutches. Integrated ribonucleic acid (RNA) synthesis will be determined during immobilization in the immobilized and non-immobilized legs using ingested deuterium oxide, salivary and blood sampling, and muscle biopsies. Immediately after immobilization, muscle biopsies will be collected before and 90 mins after consuming 25 g of whey protein from the immobilized and non-immobilized legs to characterize the intramuscular molecular response to protein feeding. Serial blood samples will be collected during that time to characterize the circulating metabolic response to protein ingestion. Knowledge generated from this effort will inform the development of targeted interventions for mitigating anabolic resistance to protein ingestion that develops during periods of muscle disuse.


Description:

Warfighters that sustain musculoskeletal injuries often experience decreased muscle loading and activation post-injury (i.e., muscle disuse) that results in a rapid loss of muscle mass and function. Loss of muscle under these conditions is attributed to a persistent negative net muscle protein balance (muscle protein synthesis [MPS] < muscle protein breakdown [MPB]) that results, in part, from a blunting of MPS in the postprandial state. Nutritional interventions that optimize postprandial MPS have been suggested as countermeasures for this "anabolic resistance" that develops during disuse to preserve muscle mass and accelerate return to duty. However, a poor understanding of mechanisms underlying anabolic resistance during disuse has made it difficult to determine an optimal nutritional intervention. The current study will address this knowledge gap directly by characterizing intramuscular molecular mechanisms underlying anabolic resistance to protein ingestion during muscle disuse. Healthy, recreationally active men and women (n=12) will be studied using a within-subjects, unilateral design. After completing baseline measures of height, weight, and body composition, participants will begin a 3-day run-in phase where they will receive diet instructions (no food provided). Muscle disuse will then be implemented for 5 days using a unilateral leg immobilization model with one leg randomly assigned to immobilization and the contralateral, active leg used as a within-subjects control. Immobilization will be implemented using a rigid knee brace, and participants will ambulate using crutches. Diets will be standardized during the immobilization phase (1.0 g protein/kg/d, 30% of energy intake from fat, and the remaining calories from carbohydrate). Integrated ribonucleic acid (RNA) synthesis will be determined during immobilization in the immobilized and non-immobilized legs using ingested deuterium oxide, salivary and blood sampling, and muscle biopsies. Immediately after immobilization, muscle biopsies will be collected before and 90 mins after consuming 25 g of whey protein from the immobilized and non-immobilized legs to characterize the intramuscular molecular response to protein feeding. Serial blood samples will be collected during that time to characterize the circulating metabolic response to protein ingestion. Knowledge generated from this effort will inform the development of targeted interventions for mitigating anabolic resistance to protein ingestion that develops during periods of muscle disuse.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - Men and women aged 18-39 years. - Body mass index (BMI) between 18.5-30 kg/m2 - Healthy without evidence of chronic illness (e.g., diabetes, cardiovascular disease, Crohn's disease) or musculoskeletal injury as determined by the USARIEM Office of Medical Oversight (OMSO) or home duty station medical support. - Routinely participate in aerobic and/or resistance exercise at least 2 days per week. - Willing to refrain from alcohol, smoking, smokeless nicotine products (includes e-cigarettes, vaping, chewing tobacco), caffeine, and dietary supplements (i.e., vitamin D, probiotics) during the run-in diet, immobilization phase, and final testing day of the study. - Supervisor approval for federal civilian employees and non-human research volunteer (HRV) active-duty military personnel stationed at Natick Soldier System Center (NSSC). - Biological females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or on continuous hormonal contraception (i.e., intrauteraine device (IUD) or oral contraceptives without placebo). Exclusion Criteria: - Musculoskeletal injuries that may interfere with the safe use of crutches. - Personal or family history of thrombosis, or prior diagnosis of deep vein thrombosis (DVT) or pulmonary embolism (PE). - Metabolic or cardiovascular abnormalities, gastrointestinal disorders, neuromuscular disorders, lower-limb amputation, or muscle/bone wasting disorders (e.g., diabetes, cardiovascular disease, Crohn's disease, etc.). - Significantly abnormal blood clotting as determined by OMSO or home duty station medical support. - Allergy to lidocaine (or similar local anesthetic) - Present condition of alcoholism, anabolic steroid use, or other substance abuse issues as determined by OMSO or home duty station medical support. - Blood donation within 8-wk of beginning the study. - Pregnant, trying to become pregnant, and/or breastfeeding (results of urine pregnancy test and self-report for breastfeeding will be obtained before body composition testing). - Unwilling or unable to consume study diets or foods provided due to personal preference and/or food allergies. - Unwilling or unable to adhere to study physical restrictions (i.e., no structured physical activity or recreational activity beyond activities of daily living) 24 hours before and during immobilization, and the final testing day. - Unwilling or unable to keep the knee brace on and walk with crutches during the immobilization phase.

Study Design


Intervention

Other:
Unilateral leg immobilization
Participants will have one leg immobilized using a rigid knee brace. Participants will be expected to keep the knee brace on for 5 days and remain non-weight bearing on the immobilized leg. Participants will use crutches to remain non-weight bearing on the immobilized leg.
Contralateral active leg
One leg will remain non-immobilized and active during the study. Participants will use this leg to walk with crutches.

Locations

Country Name City State
United States US Army Research Institute of Environmental Medicine Natick Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
United States Army Research Institute of Environmental Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Integrated ribonucleic acid (RNA) synthesis deuterium oxide coupled with muscle biopsies 5 days
Primary Intramuscular protein signaling response to protein ingestion muscle biopsies to assess protein signaling response to consuming 25 g of whey protein 90 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03662555 - Effect of Neuromuscular Electrical Stimulation Combined With Blood Flow Restriction on Muscular and Cardiovascular Function N/A
Completed NCT00060970 - Evaluating Muscle Function After Ankle Surgery N/A
Recruiting NCT05211986 - Safety and Tolerability of IMMUNA(IMM01-STEM) in Patients With Muscle Atrophy Related to Knee Osteoarthritis. Phase 1/Phase 2
Completed NCT05115643 - Brain and Muscle Plasticity During Immobilization N/A
Completed NCT03797781 - Protein Ingestion and Skeletal Muscle Atrophy N/A
Completed NCT03299972 - Multidisciplinary Research Into the Effects of Resistance Exercise and Whey Protein Supplementation in Healthy Older Men N/A
Completed NCT05072652 - Short Term Immobilization of the Lower Limb N/A
Recruiting NCT05735236 - Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation N/A
Recruiting NCT04199936 - Postoperative Electrical Muscle Stimulation (POEMS) N/A
Recruiting NCT05314413 - Examining Sex-based Differences in Metabolic and Mechanistic Responses to Disuse Induced Muscle Atrophy N/A
Recruiting NCT05823857 - Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain N/A
Active, not recruiting NCT04900701 - The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults. N/A
Completed NCT04772040 - Impact of Fish Oil Dose on Tissue Content and Function N/A
Completed NCT06088550 - Effect of Branched-chain Amino Acid Supplementation and Exercise on Muscle Quantity and Quality in Cirrhosis N/A
Enrolling by invitation NCT04456530 - Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study Phase 2/Phase 3
Recruiting NCT03551990 - Influence of Motor Proteins on Muscle Atrophy in Cancer Patients N/A
Completed NCT05206253 - Effectiveness of Egg Versus Whey Protein Powder During Resistance Training N/A
Completed NCT05382026 - Milk Versus a Pea-based Beverage for Bone and Muscle Health in Young Athletes N/A
Withdrawn NCT03069781 - The Effects of 17β-estradiol on Skeletal Muscle Early Phase 1
Recruiting NCT02221804 - The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) N/A